There are a number of new medications for psoriatic arthritis, but they generally fall into the class of drugs called TNF inhibitors or monoclonal antibodies.
Maninzi amayeza amatsha esifo sokuqaqamba kwamathambo esihamba nesifo solusu olunerhashalala, olomileyo noluxobukayo kodwa aphantsi kwecandelo lamayeza abizwa izithinteli zeTNF okanye izilwi-buhlungu ze-monoclonal.